Attached files
file | filename |
---|---|
10-Q - QUARTERLY REPORT - BLUE SPHERE CORP. | v343926_10q.htm |
EX-10.3 - EXHIBIT 10.3 - BLUE SPHERE CORP. | v343926_ex10-3.htm |
EX-32.2 - EXHIBIT 32.2 - BLUE SPHERE CORP. | v343926_ex32-2.htm |
EX-32.1 - EXHIBIT 32.1 - BLUE SPHERE CORP. | v343926_ex32-1.htm |
EX-31.2 - EXHIBIT 31.2 - BLUE SPHERE CORP. | v343926_ex31-2.htm |
EX-10.1 - EXHIBIT 10.1 - BLUE SPHERE CORP. | v343926_ex10-1.htm |
EX-10.4 - EXHIBIT 10.4 - BLUE SPHERE CORP. | v343926_ex10-4.htm |
EX-10.5 - EXHIBIT 10.5 - BLUE SPHERE CORP. | v343926_ex10-5.htm |
EX-31.1 - EXHIBIT 31.1 - BLUE SPHERE CORP. | v343926_ex31-1.htm |
Exhibit 10.2
February 19, 2013
Dr. Bornstein Ltd.
18 Reines St.
Tel Aviv, Israel
Re: Investment in Bluesphere Corp.
Dear Dr. Bornstein:
This will confirm the terms on which you will invest in Bluesphere Corp (“Bluesphere”). You will invest an aggregate of $75,000 in Bluesphere in three instalments as follows: (i) $25,000 in March 2013, (ii) $25,000 in April 2013 and (iii) $25,000 in May 2013. For each instalment of $25,000, you will receive 10,000,000 shares of our common stock. These shares will be restricted and may only be offered or sold pursuant to a registration statement under the Securities Act of 1933, as amended, or an exemption therefrom. Please indicate your acceptance of such terms by counter-signing where indicated below.
Yours truly,
Shlomi Palas, CEO
Agreed and accepted: | |
Dr. Bornstein Ltd. | |
Authorized Signatory |